SREBF1 and metabolic dysfunction-associated steatotic liver disease: SREBP-1c, the major transcriptional regulator of lipogenesis, induces the cohort of genes necessary for synthesizing fatty acids [34] and increases DNL in the liver, a hallmark of NAFLD [35].